RFK Jr.'s Push for Alternative Medicine Raises Global Questions on Safety and Policy—A Thai Perspective
Robert F. Kennedy Jr., now serving as US Secretary of Health and Human Services, has ignited international debate by vowing to dramatically expand access to experimental and alternative medical treatments in America. During a recent appearance on the “Ultimate Human” podcast, Kennedy announced his commitment to “end the war at the FDA against alternative medicine,” directly challenging longstanding regulatory practices around therapies ranging from stem cell treatments and chelation therapy to dietary supplements and hyperbaric oxygen therapy (Gizmodo, Yahoo News). While patient autonomy and the desire for broader therapeutic choices resonate with many, Kennedy’s stance has provoked fierce debate among medical professionals, regulators, and public health advocates—both in the US and abroad. For Thailand, where complementary, traditional, and alternative medicine (CAM) is interwoven into the fabric of national healthcare policy and cultural practice, Kennedy’s pronouncements serve as an opportunity for critical reflection about safety, evidence, and the role of regulation in health innovation.